Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye
Open Access
- 28 December 2017
- journal article
- research article
- Published by Springer Nature in BMC Ophthalmology
- Vol. 17 (1) , 1-15
Abstract
The aim of this research is to initiate a 5-year natural history study of dry eye disease (DED) using objectively assessed and patient-reported outcomes, to explore the hypothesis that DED is a progressive condition that has substantive and measurable impacts not only on the ocular surface, but on quality of life and visual functioning. Our objective for this report is to examine the baseline data. A multicenter, prospective, controlled, observational study of Level 2 (mild-to-moderate) DED patients based on International Task Force Delphi Panel severity grading, and controls, documented baseline measures (including tear film biomarkers and quality of life). Tear cytokine concentrations were also measured in the tear film. Patients were using artificial tears as needed. Two hundred seventeen DED patients and 67 gender- and age-matched controls were enrolled. A majority were females and Caucasian and groups did not differ significantly in terms of gender, race, or age. Differences between DED and matched controls, at baseline, included mean scores for Ocular Surface Disease Index (31.7 vs 4.1, P < 0.0001), Schirmer test (5.7 vs 15.3 mm, P < 0.0001), corneal staining (1.4 vs 0.2, P < 0.0001), conjunctival staining (1.4 vs 0.3, P < 0.0001), and tear break-up time (5.7 vs 8.5 s, P < 0.0001). Tear cytokines levels were determined and included interferon-γ, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, tumor necrosis factor-α, epidermal growth factor, IL-13, IL-17, IL-1α, and inducible protein-10. The mean levels of IL-8 and IL-6 were slightly higher in the DED group at baseline. Blurred vision was reported as moderate/severe/very severe at baseline in 57.6% of DED patients vs.10.5% of normal controls (P < 0.0001). DED patients reported greater reductions in work and non-work productivity, as well as greater need for visits to ophthalmologists during the prior year. In this report of the baseline findings of a 5-year natural history study of DED, a striking disease burden is observed with regard to blurred vision, productivity, and visits to eye care practitioners in mild to moderate DED patients compared to normal subjects of similar ages and genders. ClinicalTrials.gov NCT00833235 on January 30, 2009.Keywords
Funding Information
- Allergan, plc, Dublin, Ireland
This publication has 21 references indexed in Scilit:
- Mechanisms of Visual Disturbance in Dry EyeCornea, 2016
- Functional impairment of reading in patients with dry eyeBritish Journal of Ophthalmology, 2016
- Analysis of Tear Cytokines and Clinical Correlations in Sjögren Syndrome Dry Eye Patients and Non–Sjögren Syndrome Dry Eye PatientsAmerican Journal of Ophthalmology, 2013
- Dry Eye as a Mucosal Autoimmune DiseaseInternational Reviews of Immunology, 2013
- Evaluation of Reading Speed and Contrast Sensitivity in Dry Eye DiseaseOptometry and Vision Science, 2013
- Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye diseaseProgress in Retinal and Eye Research, 2012
- A Simplified Quantitative Method for Assessing Keratoconjunctivitis Sicca From the Sjögren's Syndrome International RegistryAmerican Journal of Ophthalmology, 2010
- Prevalence of Dry Eye Disease Among US MenArchives of Ophthalmology (1950), 2009
- Dysfunctional Tear SyndromeCornea, 2006
- Prevalence of dry eye among an elderly Chinese population in TaiwanOphthalmology, 2003